← The Wire
TOVXNYSE
Theriva Biologics, Inc.
Pharmaceutical Preparations · NV · CIK 894158
Developing oncolytic adenovirus therapeutics to treat cancer and related diseases
$14M
Market cap
$0.26
Last close
+4.1%
1D
+2.8%
5D
1.2M
Volume
Price · last 39 sessions-31.5%
May 4L $0.24 · H $0.38Jun 29
572
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
424B5424B5Dec 3, 2025424B5424B5Oct 29, 2025424B5424B5Oct 24, 2025424B5424B5Oct 16, 2025424B5424B5Oct 16, 2025424B5424B5Oct 16, 2025424B5424B5Oct 16, 2025424B5424B5Jun 20, 2025424B5424B5May 8, 2025424B5424B5Sep 27, 2024424B5424B5Sep 26, 2024424B5424B5Dec 5, 2022424B5424B5Feb 19, 2021424B5424B5Feb 10, 2021424B5424B5Feb 4, 2021424B5424B5Jan 19, 2021424B5424B5Jan 6, 2021424B5424B5Nov 17, 2020424B5424B5Nov 15, 2016424B5424B5Nov 15, 2016424B5424B5Aug 5, 2016424B5FORM 424B5Jul 17, 2015424B5FORM 424B5Jul 15, 2015424B5424B5Apr 21, 2015424B5424B5Oct 10, 2014424B5424B5Dec 11, 2013424B5424B5Apr 11, 2011424B5424B5Feb 2, 2011424B5PROSPECTUS SUPPLEMENTJul 2, 2010
Similar companies
Comparable business profile · signals at a glance